Archives for March 26, 2007

← 2007

Charles River wants a piece of the Chinese market pie

By  Emilie Reymond

Contract research organisation (CRO) Charles River Laboratories has announced it will establish a presence in China by signing a joint venture deal with Shanghai BioExplorer, a Chinese preclinical services provider.

Rhodia to close French intermediates site

By  Peter Mansell

French chemicals company Rhodia has decided to shut down a local production site for its Rhodia Organics business, citing competitive pressures in the market for pharmaceutical and agrochemical intermediates.

Dow and Colorcon in controlled release collaboration

By  Anna Lewcock

Major chemical manufacturer Dow has struck a deal with long-term partner Colorcon forming an alliance to offer a unified package for the development and production of drug ingredients and products.

Novartis and Bayer bury the Betaseron hatchet

By  Anna Lewcock

Novartis and Bayer Schering Pharma have come to an agreement regarding the production of multiple sclerosis (MS) drug Betaseron (interferon beta-1b), with Novartis planning to bring out its own version in 2009 and Bayer paying around $200m (€150.5m)...